Kenvue stock trades ex-dividend as income focus grows

Published on 09/21/2026 at 19:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Kenvue stock goes ex-dividend on September 21, 2026 with a quarterly payout of USD 0.21 per share, equal to an annualized yield near 4.7 percent based on recent prices. Recent estimates point to Q2 2026 revenue of USD 3.96 billion and profit margin above 11 percent.

Isometrische 3D-Illustration einer Konsumgüter-Lieferkette mit Fabrik und Lager — Isometrisches 3D-Diagramm der Wertschöpfungskette illustriert Produktion und Vertrieb von Kenvue ISIN US49177J1025, Illustration mit AI erstellt.

Kenvue stock (ISIN US49177J1025) offers investors a visible income signal on September 21, 2026, as the consumer health group’s shares trade ex-dividend for a quarterly cash payout of USD 0.21 per share, corresponding to an annualized dividend of USD 0.84 and a yield of about 4.7 percent based on recent prices according to Yahoo Finance.

Dividend event and income profile

Per a recent dividend summary, Kenvue’s ex-dividend date for the USD 0.21 cash distribution is set for September 21, 2026, meaning shareholders of record as of that date qualify for the upcoming payout while new buyers on September 21, 2026 will not receive this quarter’s dividend according to Yahoo Finance.

The quarterly dividend of USD 0.21 per share scales to an annualized USD 0.84, which implies a dividend yield of around 4.7 percent when measured against recent trading levels noted in the same overview, positioning Kenvue as a relatively high-yield name within the consumer health segment compared with many larger household staples peers according to Yahoo Finance.

Latest earnings and growth figures

Kenvue’s most recent reported quarter, Q2 fiscal year 2026, shows that the company generated revenue of USD 3.96 billion and earnings of USD 456 million, translating into a profit margin of 11.53 percent according to quarterly earnings trend data from Yahoo Finance.

Compared with year-ago sales of USD 3.76 billion, the Q2 2026 revenue level of USD 3.96 billion reflects an increase of about 5.3 percent, underscoring mid-single-digit top-line growth in the most recent quarter according to the same earnings-trend section from Yahoo Finance.

Analyst consensus compiled in the revenue-estimate tables points to expected current-quarter sales of roughly USD 3.86 billion for the quarter ending September 2026 and full-year 2026 revenue of around USD 15.6 billion, with growth estimates indicating a projected 9.47 percent increase in revenue for fiscal 2026 compared with the prior year according to Yahoo Finance.

Analyst view and risk context

The same analyst overview shows that for Q2 fiscal 2026, Kenvue delivered normalized earnings per share of USD 0.31, slightly below the average analyst estimate of roughly USD 0.319, pointing to a marginal earnings miss of about USD 0.009 per share even as revenue and margin held up according to Yahoo Finance.

Growth projections in the same dataset indicate that analysts expect Kenvue’s revenue to expand by 5.19 percent in the current quarter and 9.47 percent in the current fiscal year, before moderating to around 4.86 percent in 2027, highlighting a profile of steady but not explosive expansion according to Yahoo Finance.

In the broader staples and household-products universe, commentary on major sector peers such as Clorox and Kimberly-Clark has recently emphasized the importance of dividend sustainability and integration risk, including references to a pending USD 48.7 billion Kenvue-related acquisition as a potential medium-term overhang for the sector, underlining that corporate actions and execution risk can influence how investors rate household staples dividends according to 24/7 Wall St.

Stock performance and valuation snapshot

Recent quote data show Kenvue stock changing hands around USD 17.81 on the New York Stock Exchange at the close on September 18, 2026, with a modest daily decline of about 0.34 percent, followed by a small after-hours uptick to USD 17.86 later that day, illustrating relatively tight short-term price moves around the high-teens level per NYSE quote figures summarized by Yahoo Finance.

Based on a recent market-capitalization snapshot around the September 18, 2026 close, Kenvue’s equity value is reported at approximately USD 34.21 billion, placing the company firmly in the large-cap bracket among global consumer health and household staples names according to valuation data referenced in a recent market overview.

Kenvue stock price as of last close

As of the latest completed trading session on September 18, 2026, Kenvue stock closed at about USD 17.81 on the New York Stock Exchange, with the prior close only marginally higher and the daily move limited to roughly negative 0.34 percent, while the company’s market capitalization stood near USD 34.21 billion in USD terms at that date based on major exchange and portal data.